methionine has been researched along with ristocetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anbo, H; Handa, M; Ikeda, Y; Kitaguchi, T; Moriki, T; Murata, M; Takahashi, H; Watanabe, K | 1 |
| De Cristofaro, R; De Filippis, V; Lancellotti, S; Mannucci, PM; Palla, R; Peyvandi, F; Pitocco, D; Pozzi, N; Rocca, B; Rutella, S | 1 |
2 other study(ies) available for methionine and ristocetin
| Article | Year |
|---|---|
Expression and functional characterization of an abnormal platelet membrane glycoprotein Ib alpha (Met239 --> Val) reported in patients with platelet-type von Willebrand disease.
Topics: Analysis of Variance; Humans; Methionine; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Point Mutation; Recombinant Proteins; Ristocetin; Transfection; Valine; von Willebrand Diseases | 1997 |
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Binding Sites; Blood Platelets; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Humans; Hydrolysis; Male; Methionine; Middle Aged; Oxidative Stress; Peptide Fragments; Peroxynitrous Acid; Platelet Aggregation; Protein Multimerization; Ristocetin; Tyrosine; von Willebrand Diseases; von Willebrand Factor | 2010 |